Our study only explored the effects of IL-1β on ovarian cancer cell lines, and its effects on tumor-associated macrophages and fibroblasts, as well as in vivo experiments and clinical analyses, need to be further studied. The gene discussed is IL1B; the disease is ovarian carcinoma.